A Chinese pharmaceutical maker is in talks with several countries to get emergency approval to use an experimental Covid-19 vaccine, developed with the Chinese military, before the completion of large-scale safety and effectiveness trials, according to a senior executive at the company. Early distribution by CanSino Biologics Inc. would give the company a head start over rivals by making its vaccine the first to go into public use internationally outside of clinical trials, although initial doses would likely be directed at...

Source: Wall Street Journal August 28, 2020 11:01 UTC